{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:30:23Z","timestamp":1790998223864,"version":"4.1.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01008","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:16:16Z","timestamp":1526516176000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Renal Involvement in Antiphospholipid Syndrome"],"prefix":"10.3389","volume":"9","author":[{"given":"Alonso","family":"Turrent-Carriles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Herrera-F\u00e9lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Carmen","family":"Amigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"3","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B2","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s40620-016-0317-2","article-title":"Renal involvement in primary antiphospholipid syndrome","volume":"29","author":"Marcantoni","year":"2016","journal-title":"J Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/rheumatology\/kew307","article-title":"Kidney disease in primary antiphosdpholipid syndrome","volume":"56","author":"Gracia-Tello","year":"2017","journal-title":"Rheumatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2215\/CJN.00460110","article-title":"Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients","volume":"5","author":"Sinico","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.20433","article-title":"Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome","volume":"50","author":"Tektonidou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.rheuma.2008.12.011","article-title":"Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE)","volume":"5","author":"Miranda","year":"2009","journal-title":"Rheumatol Clin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/0961203310397410","article-title":"Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus","volume":"20","author":"Silvari\u00f1o","year":"2011","journal-title":"Lupus"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.005","article-title":"ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","author":"Whelton","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4103\/1947-2714.168669","article-title":"Eigth joint national committee(JNC-8) guidelines and the outpatients management of hypertension in the African-American population","volume":"10","author":"Abel","year":"2015","journal-title":"N Am J Med Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2230.1984.tb00856.x","article-title":"The Prosser-White oration 1983. Connective tissue disease and the skin","volume":"9","author":"Hughes","year":"1984","journal-title":"Clin Exp Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/art.1780290121","article-title":"Accelerated hypertension associated with lupus anticoagulant and false positive VDRL in systemic lupus erythematosus","volume":"29","author":"Jouquan","year":"1986","journal-title":"Arthritis Rheum"},{"key":"B14","first-page":"479","article-title":"Malignant hypertension in the antiphospholipid syndrome (APS) without lupus nephritis","volume":"11","author":"Cacoub","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"B15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1191\/0961203304lu1082oa","article-title":"Antiphospholipid antibodies and hypertension","volume":"13","author":"Rollino","year":"2004","journal-title":"Lupus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/01.CIR.98.11.1092","article-title":"Antibodies to endothelial cells in borderline hypertension","volume":"15","author":"Frostegard","year":"1998","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/rheumatology\/keg302","article-title":"Endstage renal failure in primary antiphospholipid syndrome-case report and review of literature","volume":"42","author":"Dayal","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/ard.49.3.184","article-title":"Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome","volume":"49","author":"Ostuni","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"B20","first-page":"1413","article-title":"Hypertension, renal artery stenosis on the \u201cprimary\u201d antiphospholipid syndrome","volume":"18","author":"Asherson","year":"1991","journal-title":"J Rheumatol"},{"key":"B21","first-page":"1806","article-title":"Bilateral renal artery occlusion in a patient with the primary antiphospholipid syndrome: thrombosis, vasculitis or both?","volume":"19","author":"Ames","year":"1992","journal-title":"J Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/ard.51.10.1180-b","article-title":"Anticardiolipin antibodies and renovascular hypertension","volume":"51","author":"Rossi","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/qjmed\/93.2.127","article-title":"Antiphospholipid syndrome and renal artery stenosis","volume":"93","author":"Godfrey","year":"2000","journal-title":"QJM"},{"key":"B24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard.62.10.999","article-title":"Renal artery stenosis in the antiphospholipid (Hughes) syndrome and renal artery stenosis","volume":"62","author":"Sangle","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/rheumatology\/keg248","article-title":"Cross-reactivity between anticardiolipin, anti-high-density lipoprotein and anti-apolipoprotien A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"42","author":"Delgado Alves","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"B26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02231583","article-title":"Circulating intercellular adhesion molecules-1 and autoantibodies in including antiendothelial cells anticardiolipin and antineutrophil cytoplasmic antibodies in patients with vasculitis","volume":"12","author":"Wang","year":"1993","journal-title":"Clin Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/08860220601166305","article-title":"Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR, and digital substraction angiography","volume":"29","author":"Rountas","year":"2007","journal-title":"Ren Fail"},{"key":"B28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/rheumatology\/keh490","article-title":"Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation","volume":"44","author":"Sangle","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0272-6386(96)90109-2","article-title":"Renal infarction and thrombosis of the infrarenal aorta in 35 year-old man with primary antiphospholipid syndrome","volume":"27","author":"Pousx","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12016-008-8112-z","article-title":"Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy","volume":"36","author":"Tektonidou","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrneph.2014.38","article-title":"Renal involvement in antiphospholipid syndrome","volume":"10","author":"Sciascia","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0272-6386(95)90603-7","article-title":"Complete recovery from renal infarcts in a patient with mixed connective tissue disease","volume":"26","author":"Perinbasekar","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"B33","first-page":"1221","article-title":"Primary antiphospholipid antibody syndrome, renal infarction and hypertension","volume":"20","author":"Sonpal","year":"1993","journal-title":"J Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/ndt\/gfq356","article-title":"What nephrologists need to know about antiphospholipid syndrome","volume":"25","author":"Alchi","year":"2010","journal-title":"Nephrol Dial Trasplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.revmed.2011.01.006","article-title":"Renal infarction in systemic lupus with antiphospholipid syndrome: role of hydroxychloroquine withdrawal?","volume":"32","author":"Zenone","year":"2011","journal-title":"Rev Med Interne"},{"key":"B36","first-page":"465","article-title":"Hypertension and the antiphospholipid antibodies","volume":"11","author":"Asherson","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1001\/archinte.1985.00360080059007","article-title":"Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants","volume":"145","author":"Glueck","year":"1985","journal-title":"Arch Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/art.1780270509","article-title":"Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus","volume":"27","author":"Mintz","year":"1984","journal-title":"Arthritis Rheum"},{"key":"B39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0049-0172(94)90086-8","article-title":"Renal manifestations of the antiphospholipid syndrome","volume":"23","author":"Piette","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"B40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.V15777","article-title":"Anti-cardiolipin antibody and renal disease: a report of three cases","volume":"1","author":"D\u2019Agati","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000168093","article-title":"Systemic and renal fibrinolytic activity in a patient with anticardiolipin syndrome and renal thrombotic microangiopathy","volume":"10","author":"Becquemont","year":"1990","journal-title":"Am J Nephrol"},{"key":"B42","first-page":"1181","article-title":"Renal involvement in primary antiphospholipid syndrome","volume":"19","author":"Amigo","year":"1992","journal-title":"J Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/qjmed\/93.7.457","article-title":"The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury","volume":"93","author":"Griffiths","year":"2000","journal-title":"QJM"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/0961203314538687","article-title":"Identification and treatment of APS renal involvement","volume":"23","author":"Tektonidou","year":"2014","journal-title":"Lupus"},{"key":"B45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/096120339900800613","article-title":"Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?","volume":"8","author":"Cerveny","year":"1999","journal-title":"Lupus"},{"key":"B46","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1191\/0961203303lu461oa","article-title":"Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy","volume":"12","author":"Korkmaz","year":"2003","journal-title":"Lupus"},{"key":"B47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1681\/ASN.V4128","article-title":"Reversible renal-failure in the primary antiphospholipid syndrome-a report of 2 cases","volume":"4","author":"Sokunbi","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/art.37759","article-title":"A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome","volume":"65","author":"Erkan","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B49","first-page":"1983","article-title":"Antiphospholipid syndrome nephropathy in catastrophic, primary and systemic lupus erythematosus-related APS","volume":"35","author":"Tektonidou","year":"2008","journal-title":"J Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0272-6386(03)00352-4","article-title":"The expanding spectrum of renal diseases associated with antiphospholipid syndrome","volume":"41","author":"Fakhouri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B51","first-page":"724","article-title":"Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis","volume":"92","author":"Zea Mendoza","year":"1989","journal-title":"Med Clin (Barc)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.ajkd.2003.09.011","article-title":"Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis","volume":"43","author":"Moroni","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0272-6386(12)80519-1","article-title":"Glomerulonephritis in a patient with anticardiolipin antibody","volume":"15","author":"Wilkowski","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5414\/CNP63471","article-title":"Kidney disease associated with primary antiphospholipid syndrome: clinical signs and histopathological features in an experience of five cases","volume":"63","author":"Saracino","year":"2005","journal-title":"Clin Nephrol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000045804","article-title":"Idiopathic membranous glomerulonephritis associated with primary antiphospholipid syndrome","volume":"86","author":"Dorel","year":"2000","journal-title":"Nephron"},{"key":"B56","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0272-6386(12)80378-7","article-title":"Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus","volume":"23","author":"Quereda","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00005792-198103000-00001","article-title":"Glomerular thrombosis in systemic lupus erythematosus. Prevalence and significance","volume":"60","author":"Kant","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"A270","DOI":"10.1136\/annrheumdis-2013-eular.1","article-title":"Secondary antiphospholipid syndrome nephropathy and lupus nephritis: a case-control study","volume":"72","author":"P\u00e9rez-Vel\u00e1squez","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","article-title":"Antiphospholipid syndrome nephropathy in systemic lupus erythematosus","volume":"13","author":"Daugas","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000013615","article-title":"Anticardiolipin antibodies in South African patients with lupus nephritis","volume":"20","author":"Naiker","year":"2000","journal-title":"Am J Nephrol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","article-title":"Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis","volume":"91","author":"Bhandari","year":"1998","journal-title":"QJM"},{"key":"B62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/RHU.0000000000000425","article-title":"Renal thrombotic microangiopathy in proliferative lupus nephritis: risk factors and clinical outcomes: a case-control study","volume":"22","author":"Barrera-Vargas","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/acr.22200","article-title":"Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients","volume":"66","author":"Jordan","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B64","first-page":"2817","article-title":"Primary antiphospholipid syndrome: functional outcome after 10 years","volume":"27","author":"Erkan","year":"2000","journal-title":"J Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00467-004-1491-3","article-title":"End-stage renal disease from glomerulonephritis associated with antiphospholipid syndrome","volume":"19","author":"Butani","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1399-0012.2012.01625.x","article-title":"Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome","volume":"26","author":"Vaidya","year":"2012","journal-title":"Clin Transplant"},{"key":"B67","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.rdc.2006.05.004","article-title":"Kidney disease in antiphospholipid syndrome","volume":"32","author":"Amigo","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"B68","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0272-6386(12)80383-0","article-title":"Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies","volume":"23","author":"Prieto","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1136\/bmj.300.6741.1696","article-title":"Raised concentrations of antibodies to cardiolipin in patients receiving dialysis","volume":"300","author":"Gr\u00f6nhagen-Riska","year":"1990","journal-title":"BMJ"},{"key":"B70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF01698134","article-title":"Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus","volume":"65","author":"Sitter","year":"1992","journal-title":"Ann Hematol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ndt\/6.8.543","article-title":"Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease","volume":"6","author":"Garc\u00eda-Mart\u00edn","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"B72","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ki.1995.352","article-title":"Antiphospholipids in hemodialysis patients. Relationship between lupus anticoagulant and thrombosis","volume":"48","author":"Brunet","year":"1995","journal-title":"Kidney Int"},{"key":"B73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0003-4975(99)00458-0","article-title":"Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients","volume":"68","author":"Fastenau","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"B74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","article-title":"Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis","volume":"26","author":"Prakash","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0049-3848(93)90229-H","article-title":"Beta-2Glycoprotein I-dependent and I-independent anticardiolipin antibody in patients with end-stage renal-disease","volume":"72","author":"Matsuda","year":"1993","journal-title":"Thromb Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.transproceed.2004.12.151","article-title":"Management of end-stage renal disease patients with antiphospholipid antibody syndrome","volume":"37","author":"Vaidya","year":"2005","journal-title":"Transplant Proc"},{"key":"B77","first-page":"428","article-title":"IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis","volume":"56","author":"Adler","year":"2001","journal-title":"Clin Nephrol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000045833","article-title":"Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect?","volume":"86","author":"Haviv","year":"2000","journal-title":"Nephron"},{"key":"B79","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1191\/0961203303lu401oa","article-title":"Antiphospholipid antibodies and renal transplantation: a risk assessment","volume":"12","author":"McIntyre","year":"2003","journal-title":"Lupus"},{"key":"B80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00007890-199907270-00014","article-title":"Antiphospholipid antibodies are a risk factor for early renal allograft failure","volume":"68","author":"Wagenknecht","year":"1999","journal-title":"Transplantation"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1111\/j.1600-6143.2010.03233.x","article-title":"Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies","volume":"10","author":"Canaud","year":"2010","journal-title":"Am J Transplant"},{"key":"B82","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-0012.1994.tb00952.x","article-title":"Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid syndrome (PAPS)","volume":"8","author":"Mondrag\u00f3n-Ram\u00edrez","year":"1994","journal-title":"Clin Transplant"},{"key":"B83","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11926-000-0089-4","article-title":"Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis","volume":"2","author":"Amigo","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"B84","first-page":"S5","article-title":"A risk-stratified perioperative management strategy for antiphospholipid antibody positive patients undergoing kidney transplantation","volume":"66","author":"Domingues","year":"2014","journal-title":"Arthritis Rheum"},{"key":"B85","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMe1406870","article-title":"The mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Eikelboom","year":"2014","journal-title":"N Engl J Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.thromres.2004.06.031","article-title":"Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cell: a pathway to targeted therapies","volume":"114","author":"Pierangeli","year":"2014","journal-title":"Thromb Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1172\/JCI118276","article-title":"Activation of cultured vascular endotelial cells by antiphospholipid antibodies","volume":"96","author":"Simantov","year":"1995","journal-title":"J Clin Invest"},{"key":"B88","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonalanti-beta 2-glycoprotein 1 antibodies react in vitro with endotelial cellsthrough adherent beta 2-glycoprotein 1 and induce endotelial activation","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B89","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1160\/TH03-07-0487","article-title":"Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome","volume":"91","author":"Dignat-George","year":"2004","journal-title":"Thromb Haemost"},{"key":"B90","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.thromres.2014.11.011","article-title":"Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations","volume":"135","author":"Chaturvedi","year":"2015","journal-title":"Thromb Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"829","DOI":"10.4330\/wjc.v7.i12.829","article-title":"Do neutrophil extracelular traps contribute to the heightened risk of thrombosis in inflammatory diseases?","volume":"7","author":"Rao","year":"2015","journal-title":"World J Cardiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.autrev.2015.08.011","article-title":"Delineating the deranged immune system in the antiphospholipid syndrome","volume":"15","author":"van den Hoogen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B93","first-page":"66","article-title":"Degradation of neutrophil extracelular traps is decreased in patients with antiphospholipid syndrome","volume":"32","author":"Leffler","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/art.21009","article-title":"Involvement of p38 MAPK in the up-regulation of tissue factor on endotelial cells by antiphospholipid antibodies","volume":"52","author":"Vega-Ostertag","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1111\/j.1538-7836.2008.03021.x","article-title":"Platelet activation by dimeric beta 2-glycoprotein 1 requires signalling with both glycoprotein 1balpha and apolipoprotein E receptor 2","volume":"6","author":"Urbanus","year":"2008","journal-title":"J Thromb Haemost"},{"key":"B96","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N Engl J Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/art.21157","article-title":"Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia","volume":"52","author":"Pierangeli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B98","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/art.21549","article-title":"Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB\/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1\/ERK pathway","volume":"54","author":"L\u00f3pez-Pedrera","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0038-1650220","article-title":"Beta2-glycoprotein 1 modulates the anticoagulant activity of activated protein C on the phospholipid surface","volume":"75","author":"Mori","year":"1996","journal-title":"Thromb Haemost"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3899\/jrheum.100494","article-title":"Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome","volume":"37","author":"Ames","year":"2010","journal-title":"J Rheumatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","article-title":"Aniphospholipid antibodies affect throphoblast gonadotropin secretion and invasiveness by binding directly and through adhered b2-glycoprotein 1","volume":"43","author":"Di Simone","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B103","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.placenta.2005.09.007","article-title":"Aberrations of early throphoblast differentiation predispose to pregnancy failure: lessons from the antiphospholipid syndrome","volume":"27","author":"Bose","year":"2006","journal-title":"Placenta"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and cause fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J Exp Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ajog.2011.06.019","article-title":"Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome","volume":"205","author":"Hunt","year":"2011","journal-title":"Am J Obstet Gynecol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01008\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:49:38Z","timestamp":1751629778000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01008\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":105,"alternative-id":["10.3389\/fimmu.2018.01008"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01008","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"article-number":"1008"}}